Hey Just seen this article. Seems good news for us all
It is good news, but just to clarify: the article states that the APPLICATION for approval has been accepted, not the drug itslef. It's stil ahead of the estimates of June for submission and it appears to still be on a "fast track" for the approval process, but again, the drug itself is still not approved for general use.
One step closer though- and all steps forward are good ones
Also, it's been approved for expanded compassionate use which means any clinc/hospital currently utilizing PD-1 in trial can give it to other patients not on trials.
Meet and talk to others about melanoma in our forums:
See also: History of the MPIP Forum
–CURE OM Forum
Or, visit the MRF Chat Room!
Submit your own patient story or read about the experiences of others.
Submit a memorial of a loved one to be posted on the MRF’s memorial wall.
Subscribe to get updates about melanoma & the MRF’s work in research, education & advocacy.
Helpline: (877) 673-6460
1411 K Street, NW Suite 800
Washington, DC 20005
(800) 673-1290 Office
(202) 347-9678 Fax
The Melanoma Research Foundation (MRF) is leading the melanoma community to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy.
The Melanoma Research Foundation is a 501(c)(3) non-profit organization.